AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
GlobeNewswire
Patient advocacy group continues push to reduce costs, improve access
Washington, DC, March 18, 2024 (GLOBE NEWSWIRE) --..
Patient advocacy group continues push to reduce costs, improve access
Washington, DC, March 18, 2024 (GLOBE NEWSWIRE) --..
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors Market Size,..
"Zvukový záznam je z interní schůzky ve společnosti AstraZeneca. Viceprezident Mark Esser říká, že jsme v roce..